Valbiotis SA (EPA:ALVAL)

Valbiotis Statistics

Total Valuation

Valbiotis has a market cap or net worth of EUR 19.40 million. The enterprise value is 11.52 million.

Market Cap	19.40M
Enterprise Value	11.52M

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Valbiotis has 23.66 million shares outstanding. The number of shares has increased by 11.98% in one year.

Current Share Class	23.66M
Shares Outstanding	23.66M
Shares Change (YoY)	+11.98%
Shares Change (QoQ)	+0.61%
Owned by Insiders (%)	3.01%
Owned by Institutions (%)	4.46%
Float	22.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	40.92
PB Ratio	1.65
P/TBV Ratio	1.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.04
EV / Sales	24.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.17

Financial Position

The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.46.

Current Ratio	3.43
Quick Ratio	2.87
Debt / Equity	0.46
Debt / EBITDA	n/a
Debt / FCF	-0.54
Interest Coverage	-38.95

Financial Efficiency

Return on equity (ROE) is -77.77% and return on invested capital (ROIC) is -24.56%.

Return on Equity (ROE)	-77.77%
Return on Assets (ROA)	-21.49%
Return on Invested Capital (ROIC)	-24.56%
Return on Capital Employed (ROCE)	-53.12%
Revenue Per Employee	10,773
Profits Per Employee	-252,614
Employee Count	44
Asset Turnover	0.02
Inventory Turnover	1.10

Taxes

In the past 12 months, Valbiotis has paid 36,000 in taxes.

Income Tax	36,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.11% in the last 52 weeks. The beta is -0.41, so Valbiotis's price volatility has been lower than the market average.

Beta (5Y)	-0.41
52-Week Price Change	-31.11%
50-Day Moving Average	0.75
200-Day Moving Average	0.93
Relative Strength Index (RSI)	61.92
Average Volume (20 Days)	607,116

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Valbiotis had revenue of EUR 474,000 and -11.12 million in losses. Loss per share was -0.70.

Revenue	474,000
Gross Profit	-1.87M
Operating Income	-7.87M
Pretax Income	-11.08M
Net Income	-11.12M
EBITDA	-8.55M
EBIT	-7.87M
Loss Per Share	-0.70

Balance Sheet

The company has 13.23 million in cash and 5.35 million in debt, giving a net cash position of 7.88 million or 0.33 per share.

Cash & Cash Equivalents	13.23M
Total Debt	5.35M
Net Cash	7.88M
Net Cash Per Share	0.33
Equity (Book Value)	11.75M
Book Value Per Share	0.50
Working Capital	12.36M

Cash Flow

In the last 12 months, operating cash flow was -9.71 million and capital expenditures -138,000, giving a free cash flow of -9.84 million.

Operating Cash Flow	-9.71M
Capital Expenditures	-138,000
Free Cash Flow	-9.84M
FCF Per Share	-0.42

Margins

Gross Margin	n/a
Operating Margin	-1,659.92%
Pretax Margin	-2,337.34%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Valbiotis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.98%
Shareholder Yield	-11.98%
Earnings Yield	-57.30%
FCF Yield	-50.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Valbiotis has an Altman Z-Score of 0.61 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.61
Piotroski F-Score	5